Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nintamed

2009 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of products for the management of diabetes. The company is the developer of a continuous glucose monitoring system for blood sugar and pen needles for administration of insulin.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Monitoring Equipment
Acquirer
Primary Office
  • Carl-Zeiss-Straße 45
  • 55129 Mainz
  • Germany

Nintamed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nintamed‘s full profile, request access.

Request full access to PitchBook

Nintamed Executive Team (2)

Name Title Board
Seat
Contact
Info
Rudolf Messer Chief Executive Officer
Michael Herrmann Produktmanager